In experimental systems, it has been examined for its influence on multiple physiological processes relevant to energy balance : Glucose regulation : Studied for glucose-dependent stimulation of insulin secretion and suppression of glucagon release Gastrointestinal function : Investigated for delayed gastric emptying and altered gastrointestinal motility Energy intake and body weight : Evaluated in large phase 2 and 3 research programs, including the STEP (SemaglutidE Treatment Effect in People with obesity) trial series Cardiometabolic markers : Examined for changes in blood pressure, lipid parameters, and inflammatory biomarkers Renal and hepatic endpoints : Explored as secondary or exploratory outcomes in selected studies Within laboratory environments, Semaglutide (20 mg) is commonly used for: In vitro GLP-1 receptor signaling assays Pancreatic islet and -cell biology studies Preclinical models of food intake and body-weight regulation Formulation, stability, and delivery-technology research All applications remain investigational and are conducted under controlled research conditions

And now think about the alternative: when you finally address whats behind your bodys GLP-1 imbalance, you give yourself a much better chance at lasting, natural weight loss
This can contribute to: Slower metabolism Increased skin laxity Softer body composition CoolSculpting selectively targets fat cells only
Wegovy contains semaglutide, a GLP-1 receptor agonist that works systemically to suppress appetite, slow gastric emptying, and improve glycaemic control
That means you will actually meet with one of our Doctors